1. Home
  2. PRAX vs URBN Comparison

PRAX vs URBN Comparison

Compare PRAX & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$305.51

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Urban Outfitters Inc.

URBN

Urban Outfitters Inc.

HOLD

Current Price

$77.69

Market Cap

6.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
URBN
Founded
2015
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.0B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
PRAX
URBN
Price
$305.51
$77.69
Analyst Decision
Strong Buy
Buy
Analyst Count
15
12
Target Price
$572.13
$86.91
AVG Volume (30 Days)
329.6K
1.0M
Earning Date
05-08-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.78
EPS
N/A
1.30
Revenue
N/A
$6,165,376,000.00
Revenue This Year
N/A
$10.67
Revenue Next Year
$7,758.26
$7.01
P/E Ratio
N/A
$57.06
Revenue Growth
N/A
11.07
52 Week Low
$37.25
$59.54
52 Week High
$366.52
$84.35

Technical Indicators

Market Signals
Indicator
PRAX
URBN
Relative Strength Index (RSI) 46.51 58.64
Support Level $284.87 $66.70
Resistance Level $331.21 $78.23
Average True Range (ATR) 16.88 2.66
MACD -2.16 0.44
Stochastic Oscillator 34.34 88.22

Price Performance

Historical Comparison
PRAX
URBN

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About URBN Urban Outfitters Inc.

Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the US, which accounts for about 87% of sales, as well as in other regions. Its retail nameplates are Urban Outfitters (22% of fiscal 2026 sales), Free People/Movement (26%), and Anthropologie (42%). Retail accounted for 86% of fiscal 2026 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (9% of sales). Urban Outfitters primarily markets to young adults and offers products across apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.

Share on Social Networks: